Z5L-50044-87896
5 vaccinations
5 coded responses
55 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 722 / AR
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-14
- 2021-01-21
- 2021-01-26
- 2021-02-09
- 2021-02-16
- 2021-04-07
- 2021-07-07
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Swollen L Axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Minimal tenderness/puffy left lateral chest wall lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: GoodFree text: Very minimal tenderness L lateral chest wall lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2022-01-01
- 2022-03-31
-
2022-04-12
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — days 1–6 daily, dose 4MedDRA: Fatigue, Headache, Injection site pain, Injection site swelling, Lymphadenopathy, Musculoskeletal chest pain, Nausea, Pain, Pyrexia — Feeling: Good · Site: PainFree text: For 48 hours after booster, I had pain and swelling in arm at injection site, achy, extreme tired, intermittent headache, nausea and fever, and axillary lymph node mild swelling and tender chest wall.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-26
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-05-24
-
2022-07-12
Survey response — 3 months, dose 4MedDRA: Bronchitis, Oropharyngeal pain, Paranasal sinus hypersecretion, Pre-existing disease, Throat irritation — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Allergic/Sinus drainage, scratchy/mild sore throat; early bronchitisMedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-13
- 2022-10-11
-
2022-10-14
Dose 5 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-15
-
2022-10-16
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-04-12 | Pfizer-BioNTech | No |
| 5 | 2022-10-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-12 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen L Axillary lymph node
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Minimal tenderness/puffy left lateral chest wall lymph node
Systemic reaction (other): Very minimal tenderness L lateral chest wall lymph node
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): For 48 hours after booster, I had pain and swelling in arm at injection site, achy, extreme tired, intermittent headache, nausea and fever, and axillary lymph node mild swelling and tender chest wall.
Release 12 — 3 months, dose 4
Symptoms: Allergic/Sinus drainage, scratchy/mild sore throat; early bronchitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Musculoskeletal chest pain | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release